The use of PrEP (pre-exposure prophylaxis) in Greece: Epidemiological situation and barriers to its implementation

被引:0
作者
Giannakopoulos, G. [1 ]
Sarafis, P. [2 ]
Mourtou, E. [3 ]
机构
[1] Hellen Open Univ, Patras, Greece
[2] Univ Thessaly, Dept Nursing, Larisa, Greece
[3] Agios Andreas Gen Hosp Patras, Patras, Greece
来源
ARCHIVES OF HELLENIC MEDICINE | 2024年 / 41卷 / 06期
关键词
AIDS; Health indicators; HIV; 90-90-90; PrEP; HIV;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The handling of the HIV pandemic in Greece has reached a critical point. Epidemiological data over the last decade show a halt in its declining rate. The Greek state established the pre-exposure prophylaxis (PrEP) hoping to boost the fight against HIV. This paper documents the necessity of implementing PrEP through analyzing the epidemiological indicators of the last decade in Greece and comparing them with other European countries, emphasizing the goals of the Joint United Nations program on HIV/AIDS (UNAIDS). Strategies are then proposed to overcome the obstacles arising from the economic, political and social conditions in the implementation of PrEP in Greece. The data were searched from the international literature and from databases of the World Health Organization (WHO), the UNAIDS, the European Center for Disease Prevention (ECDC) and the National Public Health Organization of Greece (EODY). Until the definitive treatment of HIV with the preparation of the corresponding vaccine and taking under consideration the effectiveness of antiretroviral drugs, it is concluded that carrying out prevention programs is the only way to handle the pandemic further. Following the example of many EU countries by implementing prevention programs, such as PrEP, Greece can achieve the goals of the Joint United Nations program until 2030.
引用
收藏
页码:834 / 840
页数:7
相关论文
共 14 条
  • [1] [Anonymous], 2019, BBC Monitoring Central Asia
  • [2] [Anonymous], 2022, HIV/AIDS surveillance in Europe 2020
  • [3] [Anonymous], 2023, Global HIV, hepatitis, STIs programmes - populations
  • [4] Preexposure Prophylaxis for the Prevention of HIV Infection Evidence Report and Systematic Review for the US Preventive Services Task Force
    Chou, Roger
    Evans, Christopher
    Hoverman, Adam
    Sun, Christina
    Dana, Tracy
    Bougatsos, Christina
    Grusing, Sara
    Korthuis, P. Todd
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (22): : 2214 - 2230
  • [5] Health Departments and PrEP: A Missed Opportunity for Public Health
    Comer, Carri
    Fernandez, Ricardo
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2022, 50 : 64 - 68
  • [6] EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL, 2021, HIV continuum of care-monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2020 progress report
  • [7] EUROPEAN MEDICINES AGENCY, 2016, First medicine for HIV pre-exposure prophylaxis recommended for approval in the EU
  • [8] Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
    Koppe, Uwe
    Marcus, Ulrich
    Albrecht, Stefan
    Jansen, Klaus
    Jessen, Heiko
    Gunsenheimer-Bartmeyer, Barbara
    Bremer, Viviane
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)
  • [9] Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
    Mayer, Kenneth H.
    Agwu, Allison
    Malebranche, David
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 1778 - 1811
  • [10] Human immunodeficiency virus (HIV) in older people
    Pratt, Gary
    Gascoyne, Kate
    Cunningham, Katherine
    Tunbridge, Anne
    [J]. AGE AND AGEING, 2010, 39 (03) : 289 - 294